95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.48%
Positive revenue growth while FSM is negative. John Neff might see a notable competitive edge here.
34.24%
Gross profit growth 1.25-1.5x FSM's 23.88%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
61.16%
EBIT growth 75-90% of FSM's 74.58%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
61.16%
Operating income growth at 75-90% of FSM's 74.58%. Bill Ackman would demand a plan to enhance operating leverage.
739.91%
Net income growth above 1.5x FSM's 0.49%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
766.67%
Positive EPS growth while FSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
766.67%
Positive diluted EPS growth while FSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
8.97%
Positive OCF growth while FSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
9.36%
Positive FCF growth while FSM is negative. John Neff would see a strong competitive edge in net cash generation.
264.31%
Similar 10Y revenue/share CAGR to FSM's 258.17%. Walter Schloss might see both firms benefiting from the same long-term demand.
9.44%
5Y revenue/share CAGR above 1.5x FSM's 2.17%. David Dodd would look for consistent product or market expansions fueling outperformance.
8.83%
3Y revenue/share CAGR at 75-90% of FSM's 11.69%. Bill Ackman would expect new product strategies to close the gap.
210.93%
10Y OCF/share CAGR at 50-75% of FSM's 391.95%. Martin Whitman might fear a structural deficiency in operational efficiency.
-17.22%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-5.79%
Negative 3Y OCF/share CAGR while FSM stands at 1055.12%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
130.83%
Net income/share CAGR at 50-75% of FSM's 215.81%. Martin Whitman might question if the firm’s product or cost base lags behind.
-42.21%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
26.90%
Positive short-term CAGR while FSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
180.93%
10Y equity/share CAGR at 50-75% of FSM's 246.06%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
22.48%
Below 50% of FSM's 88.90%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
14.01%
Below 50% of FSM's 82.66%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.61%
Firm’s AR is declining while FSM shows 43.63%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.13%
Asset growth well under 50% of FSM's 1.30%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.04%
BV/share growth above 1.5x FSM's 0.46%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.01%
We’re deleveraging while FSM stands at 9.19%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-22.36%
We cut SG&A while FSM invests at 3.72%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.